Ovarian cancer (OC) is one of the most common gynecologic tumors worldwide and one
with the highest mortality. Cisplatin (DDP) is the first platinum-based complex approved by …

Gene therapy provides a promising approach in treating cancers with high efficacy and
selectivity and few adverse effects. Currently, the development of functional vectors with …

Due to their well‐defined 3D architectures, permanent porosity, and diverse chemical
functionalities, metal–organic framework nanoparticles (MOF NPs) are an emerging class of …

Nanotechnology has played an important role in drug delivery and biomedical imaging over
the past two decades. In particular, nanoscale metal–organic frameworks (nMOFs) are …

The present review focuses on the use of Metal–Organic Frameworks,(MOFs) highlighting
the most recent developments in the biological field. This review assesses, in the first …

We summarize recent advances in application of MOFs as therapeutic agents, drug carriers,
imaging agents and biosensors in cancer biomedicine. A holistic perspective is adopted to …

The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer,
but new platinum agents have been very slow to enter the clinic. Recently, however, there …

The past two decades have witnessed rapid developments and innovations in
nanotechnology. 1− 10 Significant efforts have also been devoted to exploring clinical …

Nanoscale metal organic frameworks (NMOFs) have shown great potential in biomedicine
owing to their structural/chemical diversities, high molecular loading capacities, and intrinsic …

Nanomedicine of synergistic drug combinations has shown increasing significance in
cancer therapy due to its promise in providing superior therapeutic benefits to the current …